key: cord-0847741-jy45cfyn authors: Malagón-Rojas, Jeadran N; Rubio, Vivian; Parra-Barrera, Eliana title: Seroprevalence and seroconversions for SARS-CoV-2 infections in workers at Bogota Airport, Colombia, 2020 date: 2021-01-22 journal: J Travel Med DOI: 10.1093/jtm/taab006 sha: 11f0efda3e8f5bb03267832b7172a374faaf4526 doc_id: 847741 cord_uid: jy45cfyn Airport workers are a high-risk population for infectious diseases such as severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2). In a cohort of workers at the International Airport in Colombia, the accumulated incidence of SARS-CoV-2 and seroprevalence were 23.58% and 16.03%, respectively. A seroconversion rate of 60% was found among workers with COVID-19. Airport workers are in contact with thousands of worldwide travellers during times of spreading global tourism 1 where the job's activities have a higher risk of acquiring severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) due to highly asymptomatic or mildly infected people who travel among countries 2 and make many flight connections in airports. 3 Studies on the antibody response of the new SARS-CoV-2 have shown that the immunological response occurs mostly in mild and critical patients. 4 Besides, asymptomatic cases seem to present a lower antibody response than SARS-CoV-2 cases show a reduced antibody response as well as that the titres decays rapidly. There is a lack of studies focused on identifying the risk factors among risky economic activities such as transport, food and deliveries. This study focused on a group of airport workers to monitor the incidence of SARS-CoV-2 infection and identify the proportion of seroconversion among healthy workers from International Airport El Dorado in Bogotá, Colombia. A cross-sectional study was conducted to determine the seroprevalence of SARS-CoV-2 infection among healthy workers from an international airport. The study was designed following the recommendations of the STROBE Statement. The study was conducted from 1 June to 30 September 2020. We included airport workers between 18 and 60 years old with a direct contract from the airport. The study excluded workers who were at home-office work modality and workers with chronic diseases. The sample size was calculated using the Ministry of Health estimates for the incidence of SARS-CoV-2 infection in the general population 5 and using the OpenEpi ® statistical program. After obtaining written informed consent, a standardized questionnaire for each participant was completed to collect demographic, epidemiological and clinical information. Nasopharyngeal samples(NPS) from the workers were taken to detect SARS-CoV-2 RNA each 21st day from 16 June to 30 September. The detection of the virus was performed by reverse transcription-polymerase chain reaction (RT-PCR) as it was previously reported. 6 Blood samples (7 mL) were collected from each participant, the first in June and the second in September 2020. Blood samples were used to identify antibodies against SARS-CoV-2. Total antibodies were detected by the chemiluminescence (CLIA) technique SARS-CoV-2 IgG Architect (Abbott). The sensitivity and specificity of the CLIA test was estimated by a validation study using serum samples from confirmed SARS-CoV-2-positive (n = 111) and SARS-CoV-2-negative (n = 149) cases from Colombia. The sensitivity and specificity of the CLIA test was 85.5% [95% confidence interval (CI) 78.2%-90.3%] and 97.3% (95% CI 91.7%-99.3%), respectively. Workers who tested positive for SARS-CoV-2 were followed up at home weekly until the RT-PCR was negative. The followup at home included a symptoms survey, a clinical check-up performed by a physician and an NPS sampling from the worker and their close relative contacts. 6 To estimate the accumulated incidence and seroprevalence in the population, the proportions with their respective CI were calculated. Considering the uncertainty of the sensitivity and specificity of the test, an adjustment was carried out using the Bayesian method in R (pack RStan). A logistic regression model was used to estimate the relative risk to evaluate the differences between groups. To determine the variables for the model, we performed a literature review for SARS-CoV-2. The adjusted relative risks Odds ratio (OR), with their respective 95% CIs, were estimated to evaluate the differences between the groups using negative results as a reference. SPPS V 25 License from Instituto Nacional de Salud and R were used to carry out the statistical analysis. The level of statistical significance established was P < 0.05. The study included a total of 212 airport workers. Most of these workers were male (73.1%). The median age was 35.7 years (interquartile range 38.3) ( Table 1) . The accumulated incidence rate of SARS-CoV-2 from June to September 2020 was 23.58% (95% CI 18.37%-29.74%) (n = 50/212). The majority of the cases were asymptomatic (84% (n = 42). The incidence rate was 9 cases per 100 persons/day (95% CI 7.32-11.08). The proportion of positive RT-PCR in El Dorado was 0.6 times higher than the proportion observed in Bogota (Supplementary Figure S1) . The baseline seroprevalence (16 June 2020) was 1.12% (95% Bayesian Credibility Interval (BCI): 0-3.35%; n = 4/205). Only one of the four individuals who previously reported a diagnosis of SARS-CoV-2 showed antibodies against SARS-CoV-2. A second blood sample was taken on the 8 of September (83 days after baseline for each individual). A total of 16.03% (95% BCI: 10.43%-21.6%) (n = 31) of the participants presented a positive CLIA test. In addition, by the second blood sample, 13.20% of the individuals seroconverted with SARS-CoV-2 (n = 28/212) (95% BCI: 9.29%-18.43%). All participants (n = 4) who had positive antibodies in the baseline sample remained positive. The proportion of seroconversion among participants who were infected with SARS-CoV-2 during the observation period was 60.86% (95% CI: 46.76%-76.31%). There were no significant differences between asymptomatic and mild COVID-19 cases (p = 0.78). No risk factors were associated with seroprevalence to SARS-CoV-2 (Table 2) . To our knowledge, this is the first SARS-CoV-2 seroconversion study conducted on workers from an international airport. The incidence rate of SARS-CoV-2 infection confirmed by RT-PCR was 21.69%. We found that at the end of the study, Besides, this study reported 60% of seroconversion among workers who experienced an asymptomatic infection. These results are concordant with the reports from asymptomatic cases who have reported a seroprevalence of 50% among asymptomatic cases. 10 As long as these considerations, putting hope on reaching herd immunity through natural infection is not an alternative. This study has some limitations. First was related to the type of epidemiological design. By June 2020, SARS-CoV-2 was already circulating in Bogota. In this vein, it was not possible to differentiate exposed from non-exposed workers. This bias was approached using RT-PCR and serological antibody tests at the enrolment. The main limitation was linked to the uncertainty of where the transmission occurred. We tried to control this bias by following the relative close contacts using RT-PCR. Besides, it was possible to perform virus isolation and RNA sequencing in a limited number of cases. In conclusion, airport workers may be considered a highrisk group for SARS-CoV-2 transmission. In this group of risk, the infection of SARS-CoV-2 translates into low seroconversion rates. Estimating COVID-19 outbreak risk through air travel In-flight transmission of SARS-CoV-2: a review of the attack rates and available data on the efficacy of face masks High proportion of asymptomatic and presymptomatic COVID-19 infections in air passengers to Brunei Antibody responses against SARS-CoV-2 in COVID-19 patients Estimación del número reproductivo efectivo de la transmisión del COVID-19 en Colombia Risk perception of SARS-CoV-2 among airport workers: a mixed methods study Seroprevalence of immunoglobulin M and G antibodies against SARS-CoV-2 in China Pandemic peak SARS-CoV-2 infection and seroconversion rates in London frontline healthcare workers PAHO. SARS-CoV-2 Seroprevalence studies in Latin America studies 2020 Seroprevalence of anti-SARS-CoV-2 antibodies in COVID-19 patients and healthy volunteers up to 6 months post disease onset The authors would like to thank Yesith Toloza and Professor Claudia Gómez for the helpful advice on various technical issues examined in this paper. This project was funded by the Instituto Nacional de Salud. The authors declare that there are no conflicts of interest. The protocol and informed consent form were reviewed and approved by the Institutional Ethical Committee at Instituto Nacional de Salud under code 012/2020. All patients were informed about the study, and all volunteers signed the informed consent form. Supplementary data are available at JTM online.